SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-014048
Filing Date
2023-05-30
Accepted
2023-05-30 16:05:22
Documents
1
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3964
  Complete submission text file 0000899243-23-014048.txt   5489
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306
Business Address
Stevens Ruth E. (Reporting) CIK: 0001856230 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 23976317